The remaining 15 metabolites demonstrated a marked trend toward elevation in patients, with LysoPC(16:0/0:0), LysoPC(18:1/0:0), LysoPC(0:0/18:0), and LysoPC(20:4/0:0) decreasing in group Y.
← all excerpts
Identification of serum metabolic markers in non-obese hypertensive patients using non-targeted metabolomics.
1
—
—